Plant science could aid Alzheimer's research

September 23, 2013
Plant science could aid Alzheimer's research

A finding by an international team of plant biologists could be important in research into Alzheimer's and other age-related diseases.The study is published this week in the prestigious journal Proceedings of the National Academy of Sciences, and presents new data on the degradation of short peptides (chains of amino acid molecules) in cells.

The work is significant because it throws more light on the role of proteases, or enzymes, in disease in plants and animals, including humans.

The scientists identified and characterised a novel OligoPeptidase (OOP) from thale cress, a often studied by molecular biologists. OOP degrades small peptides that are produced following the import of proteins into mitochondria and chloroplasts. Import of proteins into these organelles is essential for cellular function and the small peptides must be destroyed because they become toxic to the cell.

"The characterisation of these pathways for peptide degradation in model species is essential for understanding the role of proteases in disease in ", said Professor Jim Whelan of UWA and La Trobe.

Presequence Protease (PreP), which was also first extensively characterised in plants, has ability to degrade the peptide beta-amyloid that forms insoluble fibres in the brain of Alzheimer's patients.

"We believe the OOP and PreP co-operate to completely break down harmful peptides that accumulate and adversely affect mitochondrial activities," said Elzbieta Glaser, Professor of Biochemistry at the University of Stockholm.

"It will be very interesting to study the human variant of OOP, and examine its role in the degradation of amyloid-beta peptide. It may be of importance for research in Alzheimer's disease and other age-related diseases."

More information: www.pnas.org/content/early/2013/09/11/1307637110.full.pdf+html

Related Stories

Type II diabetes and the Alzheimer's connection

February 1, 2013

A research team in Israel has devised a novel approach to identifying the molecular basis for designing a drug that might one day decrease the risk diabetes patients face of developing Alzheimer's disease. The team will present ...

Recommended for you

A cheaper, high-performance prosthetic knee

July 30, 2015

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Flow means 'go' for proper lymph system development

July 27, 2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.